|
|
| | 2-Bromo-5-fluoro-4-nitroaniline Basic information |
| Product Name: | 2-Bromo-5-fluoro-4-nitroaniline | | Synonyms: | BenzenaMine, 2-broMo-5-fluoro-4-nitro-;2-broMo-5-fluoro-4-nitrobenzenaMine;BenzenaMine, 2-broMo-5-fluoro-4-nitro-2;2-Bromo-5-fluoro-4-nitro-phenylamine;2-BroMo-5-fluoro-4-nitroaniline | | CAS: | 952664-69-6 | | MF: | C6H4BrFN2O2 | | MW: | 235.01 | | EINECS: | | | Product Categories: | | | Mol File: | 952664-69-6.mol |  |
| | 2-Bromo-5-fluoro-4-nitroaniline Chemical Properties |
| Boiling point | 364.5±37.0 °C(Predicted) | | density | 1.896±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | pka | -2.19±0.14(Predicted) | | Appearance | Light yellow to yellow Solid | | InChI | InChI=1S/C6H4BrFN2O2/c7-3-1-6(10(11)12)4(8)2-5(3)9/h1-2H,9H2 | | InChIKey | PKDUOURYTVRBLI-UHFFFAOYSA-N | | SMILES | C1(N)=CC(F)=C([N+]([O-])=O)C=C1Br |
| | 2-Bromo-5-fluoro-4-nitroaniline Usage And Synthesis |
| Uses | 2-Bromo-5-fluoro-4-nitroaniline is a polysubstituted aniline compound containing substituents such as bromine, nitro and fluorine atoms in the 2, 4 and 5 positions of the benzene ring, respectively. This product can be used as an intermediate for Tezacaftor, a cystic fibrosis (CF) combination used to treat patients 6 years of age and older. | | Synthesis | Bromine (2.15 mL, 42.2 mmol) was added slowly and dropwise to a mixed solution of 3-fluoro-4-nitroaniline (6.5 g, 42.2 mmol) in acetic acid (80 mL) and chloroform (25 mL) at 0 °C. The reaction mixture was stirred at room temperature for 2 hours and then poured into ice water. The pH of the mixture was adjusted to 8.0-9.0 with 10% aqueous sodium hydroxide solution under cooling in an ice bath, followed by extraction with ethyl acetate (50 mL × 3). The organic phases were combined, washed sequentially with water (80 mL × 2) and saturated saline (100 mL), dried over anhydrous sodium sulfate, and concentrated under reduced pressure to afford 2-bromo-5-fluoro-4-nitroaniline (9 g, 90% yield). The product was characterized by 1H-NMR (400 MHz, DMSO-d6): δ 8.26 (d, J=8.0 Hz, 1H), 7.07 (brs, 2H), 6.62 (d, J=9.6 Hz, 1H). | | References | [1] Patent: US2007/244159, 2007, A1. Location in patent: Page/Page column 112-113
[2] Patent: US2011/98311, 2011, A1
[3] Patent: US2015/231142, 2015, A1. Location in patent: Paragraph 1640; 1979
[4] Patent: WO2010/53471, 2010, A1. Location in patent: Page/Page column 56-57
[5] Patent: WO2016/109362, 2016, A1. Location in patent: Paragraph 00168 |
| | 2-Bromo-5-fluoro-4-nitroaniline Preparation Products And Raw materials |
|